See what the
eye can't.
MammoCheck pairs a portable thermal camera with AI to help women monitor their breast health at home - non‑invasive, radiation‑free, with clear results in minutes.
Investigational device under development. Pursuing CE marking (MDR, Class IIa) and FDA 510(k) clearance. Designed as an adjunct to - not a replacement for - clinical screening such as mammography.
Early detection
changes everything.
01 - Why it mattersnew breast cancer cases diagnosed worldwide every year.
women will face breast cancer in their lifetime.
five‑year survival when detected at a localized stage.
Sources: WHO / IARC Globocan · American Cancer Society SEER data.
Five minutes.
From home.
02 - How it worksScan
Position the MammoCamera and follow the app's guided capture. No compression, no discomfort, no radiation.
Analyze
Our AI maps thermal patterns and looks for asymmetries and changes between your scans over time.
Track & share
Receive a clear, clinician‑ready report. Monitor trends month to month and share results with your doctor.
Life keeps moving
Screening that fits into it. At home, on your schedule.
Heat tells a story
The MammoCamera reads skin temperature without contact.
AI maps the change
Patterns compared over time. Changes flagged for follow up.
Thermal imaging, read by AI.
Tumour development changes local blood flow and metabolism - and with it, skin temperature patterns. MammoCheck captures these patterns with a calibrated thermal camera and uses deep learning to surface what warrants a clinician's attention.
The MammoCheck spectrum is more than a brand gradient - it is the calibrated colour scale of our thermal maps. Cooler tissue renders in Royal Depth Blue and Crystal Lagoon; warmer regions rise through Emerald Canopy and Solar Flare Yellow into Inferno Orange.
Built on evidence.
04 - Research & RegulatoryPublications
Longitudinal thermal pattern tracking in at‑home screening
See all publications with DOI, authors and PDFs.
Clinical studies
Clinical validation study with hospital partners
Sensitivity / specificity evaluation against standard‑of‑care screening.
Multi‑site usability study (IEC 62366)
Human factors validation across target user groups.
Certifications & compliance
ISO 13485 - Quality Management System
CE marking - EU MDR, Class IIa
FDA 510(k) premarket notification
Three founders.
One mission.
05 - Team
From the journey.
06 - News & milestonesTake control of your
breast health.
Be the first to know when MammoCheck becomes available in your country - and follow our clinical and regulatory progress.
or join our clinical studies →